• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

种系突变率可预测37种脊椎动物的癌症死亡率。

Germline mutation rate predicts cancer mortality across 37 vertebrate species.

作者信息

Kapsetaki Stefania E, Compton Zachary T, Mellon Walker, Vincze Orsolya, Giraudeau Mathieu, Harrison Tara M, Abegglen Lisa M, Boddy Amy M, Maley Carlo C, Schiffman Joshua D

机构信息

Arizona Cancer Evolution Center, Arizona State University, Tempe, AZ, USA.

Center for Biocomputing, Security and Society, Biodesign Institute, Arizona State University, Tempe, AZ, USA.

出版信息

Evol Med Public Health. 2024 Aug 19;12(1):122-128. doi: 10.1093/emph/eoae016. eCollection 2024.

DOI:10.1093/emph/eoae016
PMID:39233763
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11372239/
Abstract

BACKGROUND AND OBJECTIVES

Cancer develops across nearly every species. However, cancer occurs at unexpected and widely different rates throughout the animal kingdom. The reason for this variation in cancer susceptibility remains an area of intense investigation. Cancer evolves in part through the accumulation of mutations, and therefore, we hypothesized that germline mutation rates would be associated with cancer prevalence and mortality across species.

METHODOLOGY

We collected previously published data on germline mutation rate and cancer mortality data for 37 vertebrate species.

RESULTS

Germline mutation rate was positively correlated with cancer mortality (P-value = 0.0008; R2 = 0.13). Controlling for species' average parental age, maximum longevity, adult body mass or domestication did not improve the model fit (the change (Δ) in Akaike Information Criterion (AIC) was less than 2). However, this model fit was better than a model controlling for species trophic level (ΔAIC > 2).

CONCLUSIONS AND IMPLICATIONS

The increased death rate from cancer in animals with increased germline mutation rates may suggest underlying hereditary cancer predisposition syndromes similar to those diagnosed in human patients. Species with higher germline mutation rates may benefit from close monitoring for tumors due to increased genetic risk for cancer development. Early diagnoses of cancer in these species may increase their chances of overall survival, especially for threatened and endangered species.

摘要

背景与目的

几乎每个物种都会发生癌症。然而,在整个动物界,癌症的发生几率出乎意料且差异很大。这种癌症易感性差异的原因仍是一个深入研究的领域。癌症部分是通过突变的积累而演变的,因此,我们假设种系突变率与物种间的癌症患病率和死亡率相关。

方法

我们收集了先前发表的37种脊椎动物的种系突变率数据和癌症死亡率数据。

结果

种系突变率与癌症死亡率呈正相关(P值 = 0.0008;R² = 0.13)。控制物种的平均亲本年龄、最大寿命、成年体重或驯化程度并不能改善模型拟合度(赤池信息准则(AIC)的变化(Δ)小于2)。然而,该模型拟合度优于控制物种营养级的模型(ΔAIC > 2)。

结论与启示

种系突变率增加的动物中癌症死亡率的上升可能表明存在与人类患者中诊断出的类似的潜在遗传性癌症易感性综合征。种系突变率较高的物种可能因癌症发生的遗传风险增加而受益于对肿瘤的密切监测。在这些物种中早期诊断癌症可能会增加它们的总体生存机会,特别是对于受威胁和濒危物种。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24dc/11372239/262fc7a8f84c/eoae016_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24dc/11372239/462c89f092c2/eoae016_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24dc/11372239/262fc7a8f84c/eoae016_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24dc/11372239/462c89f092c2/eoae016_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24dc/11372239/262fc7a8f84c/eoae016_fig2.jpg

相似文献

1
Germline mutation rate predicts cancer mortality across 37 vertebrate species.种系突变率可预测37种脊椎动物的癌症死亡率。
Evol Med Public Health. 2024 Aug 19;12(1):122-128. doi: 10.1093/emph/eoae016. eCollection 2024.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
4
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
5
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
6
Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?当前的生存预测工具在治疗骨转移后的骨骼相关事件时有用吗?
Clin Orthop Relat Res. 2024 Sep 1;482(9):1710-1721. doi: 10.1097/CORR.0000000000003030. Epub 2024 Mar 22.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.

引用本文的文献

1
The Elephant and the Spandrel.大象与拱肩
Evol Med Public Health. 2024 Aug 26;13(1):92-100. doi: 10.1093/emph/eoae019. eCollection 2025.
2
The relationship between diet, plasma glucose, and cancer prevalence across vertebrates.脊椎动物的饮食、血糖与癌症患病率之间的关系。
Nat Commun. 2025 Mar 12;16(1):2271. doi: 10.1038/s41467-025-57344-1.
3
Cancer Prevalence across Vertebrates.脊椎动物中的癌症患病率。

本文引用的文献

1
Life history traits and cancer prevalence in birds.鸟类的生活史特征与癌症患病率
Evol Med Public Health. 2024 Jun 27;12(1):105-116. doi: 10.1093/emph/eoae011. eCollection 2024.
2
Retrospective Study of the Prevalence, Histopathology, Therapy, and Survival Time of Neoplastic Disease in Fish.鱼类肿瘤性疾病的患病率、组织病理学、治疗及生存时间的回顾性研究
Animals (Basel). 2024 Jan 31;14(3):464. doi: 10.3390/ani14030464.
3
Is chimerism associated with cancer across the tree of life?嵌合体与生命之树中的癌症有关吗?
Cancer Discov. 2025 Jan 13;15(1):227-244. doi: 10.1158/2159-8290.CD-24-0573.
PLoS One. 2023 Jun 29;18(6):e0287901. doi: 10.1371/journal.pone.0287901. eCollection 2023.
4
Evolution of the germline mutation rate across vertebrates.脊椎动物种系突变率的演化。
Nature. 2023 Mar;615(7951):285-291. doi: 10.1038/s41586-023-05752-y. Epub 2023 Mar 1.
5
Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomas.儿童、青少年和青年期软组织肉瘤患者的遗传易感性。
Eur J Med Genet. 2023 May;66(5):104718. doi: 10.1016/j.ejmg.2023.104718. Epub 2023 Feb 9.
6
Genetic predisposition to cancers in children and adolescents.儿童和青少年患癌症的遗传易感性。
Curr Opin Pediatr. 2023 Feb 1;35(1):55-62. doi: 10.1097/MOP.0000000000001197. Epub 2022 Nov 10.
7
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.在前瞻性 MASTER 试验中进行全面的癌症易感性检测可识别遗传性癌症患者,并为罕见癌症的治疗决策提供支持。
Ann Oncol. 2022 Nov;33(11):1186-1199. doi: 10.1016/j.annonc.2022.07.008. Epub 2022 Aug 18.
8
Somatic mutational profiles and germline polygenic risk scores in human cancer.体细胞突变特征与人类癌症的种系多基因风险评分
Genome Med. 2022 Feb 11;14(1):14. doi: 10.1186/s13073-022-01016-y.
9
Cancer risk across mammals.哺乳动物的癌症风险。
Nature. 2022 Jan;601(7892):263-267. doi: 10.1038/s41586-021-04224-5. Epub 2021 Dec 22.
10
Therapeutic Implications of Germline Testing in Patients With Advanced Cancers.胚系基因检测在晚期癌症患者中的治疗意义。
J Clin Oncol. 2021 Aug 20;39(24):2698-2709. doi: 10.1200/JCO.20.03661. Epub 2021 Jun 16.